Desentum Oy is a company headquartered in Finland.
Desentum Oy is a clinical-stage biopharmaceutical company developing novel allergen immunotherapy products designed to improve the efficacy, safety, and patient experience of allergy treatments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.